{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:23:17Z","timestamp":1778217797096,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.yebeh.2021.107983","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T18:25:36Z","timestamp":1620066336000},"page":"107983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Lack of observed tolerance to diazepam nasal spray (Valtoco\u00ae) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-2977","authenticated-orcid":false,"given":"Gregory D.","family":"Cascino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3392-0327","authenticated-orcid":false,"given":"Daniel","family":"Tarquinio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-3431","authenticated-orcid":false,"given":"James W.","family":"Wheless","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Edward","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-6006","authenticated-orcid":false,"given":"Michael R.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kore","family":"Liow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian L.","family":"Rabinowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Carrazana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.107983_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/03602537808993775","article-title":"Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations","volume":"8","author":"Greenblatt","year":"1978","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.yebeh.2021.107983_b0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1528-1167.2006.00607.x","article-title":"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs","volume":"47","author":"Loscher","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107983_b0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-0404.1996.tb00180.x","article-title":"Effectiveness and tolerance of clobazam in temporal lobe epilepsy","volume":"93","author":"Barcs","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2021.107983_b0020","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.0000000000003253","article-title":"Deconstructing tolerance with clobazam: post hoc analyses from an open-label extension study","volume":"87","author":"Gidal","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.107983_b0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2021.107983_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/WCO.0000000000000177","article-title":"Seizure clusters: characteristics and treatment","volume":"28","author":"Haut","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2021.107983_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.05.013","article-title":"Seizure cluster: definition, prevalence, consequences, and management","volume":"68","author":"Jafarpour","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2021.107983_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","article-title":"Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2021.107983_b0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.0013-9580.2005.29004.x","article-title":"Seizure clustering: risks and outcomes","volume":"46","author":"Haut","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107983_b0050","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1111\/j.1528-1157.1996.tb06025.x","article-title":"Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment","volume":"37","author":"Mitchell","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107983_b0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2005.08.018","article-title":"Seizure clustering","volume":"8","author":"Haut","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107983_b0060","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/brain\/awn037","article-title":"Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy","volume":"131","author":"Sillanp\u00e4\u00e4","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2021.107983_b0065","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1528-1157.1999.tb02047.x","article-title":"An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North American Diastat Group","volume":"40","author":"Mitchell","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107983_b0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/epi.16300","article-title":"Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: an open-label extension trial","volume":"60","author":"Wheless","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107983_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13346-012-0069-z","article-title":"High efficiency intranasal drug delivery using Intravail\u00ae alkylsaccharide absorption enhancers","volume":"3","author":"Maggio","year":"2013","journal-title":"Drug Deliv Transl Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:36:57Z","timestamp":1761503817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":15,"alternative-id":["S1525505021002171"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107983","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of observed tolerance to diazepam nasal spray (Valtoco\u00ae) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107983"}}